Diabetes and sex: from pathophysiology to personalized medicine (Q38052846)

27 August 2017

title

Diabetes and sex: from pathophysiology to personalized medicine (English)

1 reference

27 August 2017

1 reference

personalized medicine

1 reference

Rosanna Abbate

1

1 reference

27 August 2017

Edoardo Mannucci

2

1 reference

27 August 2017

Gabriele Cioni

3

1 reference

27 August 2017

Cinzia Fatini

4

1 reference

27 August 2017

Rossella Marcucci

5

1 reference

27 August 2017

language of work or name

1 reference

1 October 2012

1 reference

Internal and emergency medicine

27 August 2017

published in

1 reference

27 August 2017

volume

7 Suppl 3

1 reference

27 August 2017

page(s)

S215-9

1 reference

Changes over time in the prevalence and quality of care of type 2 diabetes in Italy: the Casale Monferrato surveys, 1988 and 2000.

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11739-012-0804-Y

Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-012-0804-Y

Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-012-0804-Y

Women younger than 65 years with diabetes mellitus are a high-risk group after myocardial infarction: a report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission (RIKS-HIA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-012-0804-Y

Incidence and risk factors for stroke in type 2 diabetic patients: the DAI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-012-0804-Y

Type 2 diabetes mellitus and gender-specific risk for colorectal neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-012-0804-Y

Mechanisms of impaired bone strength in type 1 and 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-012-0804-Y

Bone metabolism and fracture risk in type 2 diabetes mellitus [Review].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-012-0804-Y

Bone fractures and hypoglycemic treatment in type 2 diabetic patients: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-012-0804-Y

Depression and type 2 diabetes over the lifespan: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-012-0804-Y

Eating disorders in patients with type 1 diabetes: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-012-0804-Y

Rosiglitazone stimulates adipogenesis and decreases osteoblastogenesis in human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-012-0804-Y

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-012-0804-Y

Dipeptidyl peptidase-4 inhibitors and bone fractures: a meta-analysis of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-012-0804-Y

Insulin therapy in diabetes and cancer risk: current understanding and implications for future study: proceedings from a meeting of a European Insulin Safety Consensus Panel, convened and sponsored by Novo Nordisk, held Tuesday October 5, 2010 at Th

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-012-0804-Y

Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-012-0804-Y

Anticancer effects of metformin and its potential use as a therapeutic agent for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-012-0804-Y

Sex differences in platelet reactivity and response to low-dose aspirin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-012-0804-Y

Profile and prevalence of aspirin resistance in patients with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-012-0804-Y

Low-dose aspirin increases aspirin resistance in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-012-0804-Y

Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-012-0804-Y

Aspirin effect on the incidence of major adverse cardiovascular events in patients with diabetes mellitus: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-012-0804-Y

A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-012-0804-Y

The relative efficacy and safety of clopidogrel in women and men a sex-specific collaborative meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-012-0804-Y

Do women exhibit greater differences in established and novel risk factors between diabetes and non-diabetes than men? The British Regional Heart Study and British Women's Heart Health Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-012-0804-Y

Comparison of aspirin resistance in type 1 versus type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-012-0804-Y

Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-012-0804-Y

Aspirin is associated with reduced cardiovascular and all-cause mortality in type 2 diabetes in a primary prevention setting: the Fremantle Diabetes study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-012-0804-Y

Aspirin Resistance in healthy drug-naive men versus women (from the Heredity and Phenotype Intervention Heart Study).

21 January 2018

1 reference

12 December 2020

Incidence of coronary heart disease in type 2 diabetic men and women: impact of microvascular complications, treatment, and geographic location

1 reference

12 December 2020

The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema

1 reference

12 December 2020

Aspirin effects on mortality and morbidity in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study report 14. ETDRS Investigators

1 reference

12 December 2020

Epidemiology of persistent proteinuria in type II diabetes mellitus. Population-based study in Rochester, Minnesota

1 reference

12 December 2020

Aspirin for primary prevention of cardiovascular events in people with diabetes

1 reference

12 December 2020

10.1007/S11739-012-0804-Y

Identifiers

DOI

1 reference

27 August 2017

1 reference